A revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...

Researchers at Pitt have produced the most detailed image to date of a bacteriophage–phage for short–that has allowed them to see for the first time the structural makeup of the part of the phage that ...

Mouse studies demonstrated that newly generated neurons connect with brain networks responsible for motor control.

U.S. raises tariffs on key imports, impacting retailers and manufacturers. Apparel, footwear, and home furnishings face steep cost increases. With stocks plunging, steady income is key. Tim Melvin ...

ChatGPT’s daily active users (DAU) in South Korea have surpassed 1.2 million for the first time, driven by the popularity of its artificial intelligence (AI) image generation feature. However, the ...

Sikandar was leaked in HD on social media. Fans have claimed that the leak is ‘full effort to sabotage image’ of Salman Khan, while others said it was a PR stunt to save the actor from a ...

Catalysis Research Laboratory (CaRLa), www.carla-hd.de, Heidelberg University, Im Neuenheimer Feld 271, 69120 Heidelberg, Germany Institute of Organic Chemistry Heidelberg University, Im Neuenheimer ...

This week, the internet had a rare opportunity to transform its selfies and family photos into stunning Studio Ghibli “portraits.” What started as a lighthearted trend quickly took a darker turn.

HD Capital Partners focuses on finding undervalued and overlooked ASX small caps for long-term gains Investment firm says some small cap tech stocks still recovering from a bear market, including ...

Earlier this week, OpenAI released their “most advanced image generator yet” and made it available through ChatGPT using the GPT-4o model. ChatGPT previously relied on Dall-E to generate images.

Alcon's acquisition of Aurion Biotech enhances its cell therapy capabilities for eye diseases, with Aurion operating independently under Alcon's support. Aurion's AURN001, an allogeneic cell therapy ...